Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Morishima

Showing results (201-210 of 334) with videos related to

Pageof 34
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1985
Treatment of plasma cell neoplasm with recombinant leukocyte A interferon and human lymphoblastoid interferonR Ohno, Y Kodera, M Ogura, et al.
The American Journal of Pathology|March 7, 2000
API2-MALT1 chimeric transcripts involved in mucosa-associated lymphoid tissue type lymphoma predict heterogeneous productsM Motegi, M Yonezumi, H Suzuki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2011
Inverse association between soy intake and non-Hodgkin lymphoma risk among women: a case-control study in JapanD Chihara, K Matsuo, J Kanda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1984
[Treatment of hematological malignancies with recombinant leukocyte A interferon (rIFN-alpha A)]R Ohno, Y Kodera, M Ogura, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 1, 1995
[Indication of allogeneic bone marrow transplantation (BMT) from HLA identical sibling in adult acute myeloblastic leukemia--comparative study of BMT and chemotherapy in patients with the first remission state. Nagoya BMT Group. Japan Adult Leukemia Study Group]Y Morishima, M Tanimoto, Y Kodera, et al.
Blood|April 15, 1994
A double-blind controlled study of granulocyte colony-stimulating factor started two days before induction chemotherapy in refractory acute myeloid leukemia. Kohseisho Leukemia Study GroupR Ohno, T Naoe, A Kanamaru, et al.
Blood|February 15, 1993
Long persistent bcr-abl positive transcript detected by polymerase chain reaction after marrow transplant for chronic myelogenous leukemia without clinical relapse: a study of 64 patientsK Miyamura, T Tahara, M Tanimoto, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 1, 1978
[A case of acute lymphoblastic leukemia treated with allogeneic bone marrow transplantation from a HLA identical sibling (author's transl)]H Takeyama, K Kawashima, Y Morishima, et al.
International Journal of Hematology|June 1, 1992
Bone marrow transplantation for chronic myelogenous leukemia in blastic phase using a phenotypically identical unrelated volunteer donor. Nagoya Bone Marrow Transplantation Group (NBMTG), Tokai Marrow Donor Bank (TMDB)Y Akatsuka, Y Kodera, K Yamamoto, et al.
International Journal of Cancer|June 15, 1984
Prevalence of possible adult T-cell leukemia virus-carriers among volunteer blood donors in Japan: a nation-wide studyY Maeda, M Furukawa, Y Takehara, et al.
Pageof 34

Showing results (201-210 of 334) with videos related to

Sort By:
Pageof 34
Cancer Chemotherapy and Pharmacology|January 1, 1985
Treatment of plasma cell neoplasm with recombinant leukocyte A interferon and human lymphoblastoid interferonR Ohno, Y Kodera, M Ogura, et al.
The American Journal of Pathology|March 7, 2000
API2-MALT1 chimeric transcripts involved in mucosa-associated lymphoid tissue type lymphoma predict heterogeneous productsM Motegi, M Yonezumi, H Suzuki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2011
Inverse association between soy intake and non-Hodgkin lymphoma risk among women: a case-control study in JapanD Chihara, K Matsuo, J Kanda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1984
[Treatment of hematological malignancies with recombinant leukocyte A interferon (rIFN-alpha A)]R Ohno, Y Kodera, M Ogura, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 1, 1995
[Indication of allogeneic bone marrow transplantation (BMT) from HLA identical sibling in adult acute myeloblastic leukemia--comparative study of BMT and chemotherapy in patients with the first remission state. Nagoya BMT Group. Japan Adult Leukemia Study Group]Y Morishima, M Tanimoto, Y Kodera, et al.
Blood|April 15, 1994
A double-blind controlled study of granulocyte colony-stimulating factor started two days before induction chemotherapy in refractory acute myeloid leukemia. Kohseisho Leukemia Study GroupR Ohno, T Naoe, A Kanamaru, et al.
Blood|February 15, 1993
Long persistent bcr-abl positive transcript detected by polymerase chain reaction after marrow transplant for chronic myelogenous leukemia without clinical relapse: a study of 64 patientsK Miyamura, T Tahara, M Tanimoto, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 1, 1978
[A case of acute lymphoblastic leukemia treated with allogeneic bone marrow transplantation from a HLA identical sibling (author's transl)]H Takeyama, K Kawashima, Y Morishima, et al.
International Journal of Hematology|June 1, 1992
Bone marrow transplantation for chronic myelogenous leukemia in blastic phase using a phenotypically identical unrelated volunteer donor. Nagoya Bone Marrow Transplantation Group (NBMTG), Tokai Marrow Donor Bank (TMDB)Y Akatsuka, Y Kodera, K Yamamoto, et al.
International Journal of Cancer|June 15, 1984
Prevalence of possible adult T-cell leukemia virus-carriers among volunteer blood donors in Japan: a nation-wide studyY Maeda, M Furukawa, Y Takehara, et al.
Pageof 34